| 12378243 |
Quinoline compounds as inhibitors of KRAS |
Qinda Ye, Matthew S. McCammant, Rocco Policarpo, Artem Shvartsbart, Wenyu Zhu +13 more |
2025-08-05 |
|
| 12083124 |
Bicyclic heterocycles as FGFR inhibitors |
Oleg Vechorkin, Minh Ngoc Nguyen, Anlai Wang, Michael Witten, Yao-Chang Xu +4 more |
2024-09-10 |
$19,871,000 |
| 12077539 |
Imidazole and triazole KRAS inhibitors |
Xiaozhao Wang, Wenqing Yao |
2024-09-03 |
$81,309,000 |
| 12060433 |
CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy |
Horacio G. Nastri, Shaun M. Stewart, Juan Carlos Almagro, Jing Zhou, Rebecca A. Buonpane +9 more |
2024-08-13 |
$73,572,000 |
| 11999740 |
Fused pyrazine derivatives as A2A / A2B inhibitors |
Xiaozhao Wang, Peter Carlsen, Pei Gan, Gia Hoang, Yong Li +3 more |
2024-06-04 |
$26,035,000 |
| 11939328 |
Quinoline compounds as inhibitors of KRAS |
Qinda Ye, Matthew S. McCammant, Artem Shvartsbart, Wenyu Zhu, Bin Hu +3 more |
2024-03-26 |
$38,229,000 |
| 11859262 |
Large-sized high-Nb superalloy ingot and smelting process thereof |
Shuo Huang, Guangpu Zhao, Beijiang Zhang, Ran Duan, Heyong Qin +2 more |
2024-01-02 |
|
| 11673894 |
Imidazopyrimidines and triazolopyrimidines as A2A / A2B inhibitors |
Xiaozhao Wang, Pei Gan, Taisheng Huang, Ding-Quan Qian, Liangxing Wu +5 more |
2023-06-13 |
$39,837,000 |
| 11607416 |
Bicyclic heterocycles as FGFR inhibitors |
Oleg Vechorkin, Minh Ngoc Nguyen, Anlai Wang, Michael Witten, Yao-Chang Xu +4 more |
2023-03-21 |
$45,871,000 |
| 11591329 |
Bicyclic heterocycles as FGFR inhibitors |
Oleg Vechorkin, Minh Ngoc Nguyen, Anlai Wang, Wenqing Yao |
2023-02-28 |
$17,306,000 |
| 11339149 |
Heterocyclic compounds as immunomodulators |
Liangxing Wu, Jingwei Li, Wenqing Yao, Ding-Quan Qian, Fenglei Zhang |
2022-05-24 |
$106,271,000 |
| 11161850 |
Fused pyrazine derivatives as A2A / A2B inhibitors |
Xiaozhao Wang, Yong Li, Liangxing Wu, Wenqing Yao, Wenyu Zhu |
2021-11-02 |
$33,545,000 |
| 11111247 |
Pyrazolopyrimidine compounds and uses thereof |
Oleg Vechorkin, Minh Ngoc Nguyen, Anlai Wang, Liangxing Wu, Wenqing Yao +1 more |
2021-09-07 |
$111,221,000 |
| 11086512 |
Information processing apparatus of displaying text with semantic segments thereof marked and determining and displaying candidate operations matching user intent corresponding to the text, information processing method thereof, and computer-readable storage medium |
Xinglin Hou, Zhuoran Wang, Yuchi Ma |
2021-08-10 |
|
| 10800768 |
Heterocyclic compounds as immunomodulators |
Liangxing Wu, Jingwei Li, Wenqing Yao, Ding-Quan Qian, Fenglei Zhang |
2020-10-13 |
$41,718,000 |
| 10442712 |
Membrane bioreactor for strengthening membrane fouling control and method thereof |
Jinnan Wang, Yaohua Lin |
2019-10-15 |
|
| 10423648 |
Method, system, and computer readable medium for interest tag recommendation |
Xiang He, Ye-Kui Wang |
2019-09-24 |
|